Curran Simpson, Chief Executive Officer at REGENXBIO Inc. (RGNX), sold 15,248 shares at $10.03 ($153K) on 2025-09-29, disclosed to the SEC on 2025-10-01.
Scheduled sale ($153k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.03 | 7,624 | $76K | 50.0% |
| 2 | $10.03 | 7,624 | $76K | 50.0% |
| Total | $10.03 avg | 15,248 | $153K | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $2K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $290K | — | Filing → |
| RGNX | SELL | 2021-01-14 | $1.2M | — | Filing → |